Bharati R Dhruva

Array ( [id] => 11236572 [patent_doc_number] => 09463204 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-10-11 [patent_title] => 'Method for inducing differentiation enabling tumorigenesis of IPS cells to be suppressed' [patent_app_type] => utility [patent_app_number] => 14/369157 [patent_app_country] => US [patent_app_date] => 2012-12-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 12594 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14369157 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9799061 [patent_doc_number] => 20150011005 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-01-08 [patent_title] => 'METHOD FOR PRODUCING CELL HAVING NUCLEIC ACID INTRODUCED THEREIN' [patent_app_type] => utility [patent_app_number] => 14/369526 [patent_app_country] => US [patent_app_date] => 2012-12-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 8089 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14369526 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11895408 [patent_doc_number] => 09765335 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-09-19 [patent_title] => 'Gene nanocomposite, and cellular internalization method of gene using same' [patent_app_type] => utility [patent_app_number] => 14/364611 [patent_app_country] => US [patent_app_date] => 2012-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5623 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14364611 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10953270 [patent_doc_number] => 20140356291 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-12-04 [patent_title] => 'IDH1-Mutated Human Glioblastoma Cell Lines and Xenografts' [patent_app_type] => utility [patent_app_number] => 14/364029 [patent_app_country] => US [patent_app_date] => 2012-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3146 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14364029 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11178142 [patent_doc_number] => 09410129 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-08-09 [patent_title] => 'Recombinant serotype 5 (Ad5) adenoviral vectors' [patent_app_type] => utility [patent_app_number] => 14/359141 [patent_app_country] => US [patent_app_date] => 2012-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 26 [patent_no_of_words] => 17490 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14359141 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15851039 [patent_doc_number] => 10640785 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-05-05 [patent_title] => Virus vectors for highly efficient transgene delivery [patent_app_type] => utility [patent_app_number] => 14/360151 [patent_app_country] => US [patent_app_date] => 2012-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 23 [patent_no_of_words] => 18627 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14360151 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11250565 [patent_doc_number] => 09476056 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-10-25 [patent_title] => 'Recombinant vector for producing and secreting peptide or protein of interest by propionibacteria and applications thereof' [patent_app_type] => utility [patent_app_number] => 13/679344 [patent_app_country] => US [patent_app_date] => 2012-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 9 [patent_no_of_words] => 13802 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13679344 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8939939 [patent_doc_number] => 20130189736 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-07-25 [patent_title] => 'ANTIBODY COMPOSITION-PRODUCING CELL' [patent_app_type] => utility [patent_app_number] => 13/672006 [patent_app_country] => US [patent_app_date] => 2012-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 52 [patent_figures_cnt] => 52 [patent_no_of_words] => 77454 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13672006 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10208455 [patent_doc_number] => 20150093444 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-04-02 [patent_title] => 'BLOCK COPOLYMER, LIQUID COMPOSITE THEREOF, NUCLEIC ACID PREPARATION, PREPARATION METHODS THEREFOR, AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 14/354496 [patent_app_country] => US [patent_app_date] => 2012-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 13334 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14354496 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8780103 [patent_doc_number] => 20130102078 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-04-25 [patent_title] => 'NANOINJECTION SYSTEM DNA PLACEMENT PIPETTE COUPLER' [patent_app_type] => utility [patent_app_number] => 13/657689 [patent_app_country] => US [patent_app_date] => 2012-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5102 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13657689 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11356310 [patent_doc_number] => 09532948 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-01-03 [patent_title] => 'Nanostructure suitable for sequestering cholesterol and other molecules' [patent_app_type] => utility [patent_app_number] => 13/651935 [patent_app_country] => US [patent_app_date] => 2012-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 34 [patent_no_of_words] => 22327 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13651935 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8638078 [patent_doc_number] => 20130029881 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-01-31 [patent_title] => 'SELECTIVE TERMINAL TAGGING OF NUCLEIC ACIDS' [patent_app_type] => utility [patent_app_number] => 13/627616 [patent_app_country] => US [patent_app_date] => 2012-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 21888 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13627616 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9719663 [patent_doc_number] => 20140255362 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-09-11 [patent_title] => 'SRPX FOR TREATMENT OF CANCER' [patent_app_type] => utility [patent_app_number] => 14/240813 [patent_app_country] => US [patent_app_date] => 2012-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 9303 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14240813 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11766885 [patent_doc_number] => 09375400 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-06-28 [patent_title] => 'Manganese ion coated nanoparticles for delivery of compositions into the central nervous system by nasal insufflation' [patent_app_type] => utility [patent_app_number] => 14/343534 [patent_app_country] => US [patent_app_date] => 2012-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 19 [patent_no_of_words] => 11474 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14343534 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8708653 [patent_doc_number] => 20130065942 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-03-14 [patent_title] => 'Nucleic Acid-Lipopolymer Compositions' [patent_app_type] => utility [patent_app_number] => 13/605462 [patent_app_country] => US [patent_app_date] => 2012-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 11469 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13605462 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8710315 [patent_doc_number] => 20130067605 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-03-14 [patent_title] => 'hnRNP A1 KNOCKOUT ANIMAL MODEL AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 13/600635 [patent_app_country] => US [patent_app_date] => 2012-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6265 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13600635 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9823562 [patent_doc_number] => 08933047 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-01-13 [patent_title] => 'Poly(acrylate) polymers for in vivo nucleic acid delivery' [patent_app_type] => utility [patent_app_number] => 13/592403 [patent_app_country] => US [patent_app_date] => 2012-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 16 [patent_no_of_words] => 24005 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13592403 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9602720 [patent_doc_number] => 20140199402 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-07-17 [patent_title] => 'NOVEL COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE' [patent_app_type] => utility [patent_app_number] => 14/238443 [patent_app_country] => US [patent_app_date] => 2012-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 9310 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14238443 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11284006 [patent_doc_number] => 09499852 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-11-22 [patent_title] => 'Wound dressing' [patent_app_type] => utility [patent_app_number] => 14/371275 [patent_app_country] => US [patent_app_date] => 2012-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 17 [patent_no_of_words] => 10002 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 127 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14371275 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9685232 [patent_doc_number] => 20140241996 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-08-28 [patent_title] => 'THERAPEUTIC NANOPARTICLES AND METHODS OF USE THEREOF' [patent_app_type] => utility [patent_app_number] => 14/233215 [patent_app_country] => US [patent_app_date] => 2012-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 21924 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14233215 [rel_patent_id] =>[rel_patent_doc_number] =>)